Get the Stockscreener App
1.10
4.35%
-0.05
After Hours:
1.11
0.01
+0.91%
Enlivex Therapeutics Ltd stock is traded at $1.10, with a volume of 279.97K.
It is down -4.35% in the last 24 hours and up +2.80% over the past month.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
See More
Previous Close:
$1.15
Open:
$1.1
24h Volume:
279.97K
Relative Volume:
0.53
Market Cap:
$26.02M
Revenue:
-
Net Income/Loss:
$-14.33M
P/E Ratio:
-1.6667
EPS:
-0.66
Net Cash Flow:
$-13.21M
1W Performance:
-3.93%
1M Performance:
+2.80%
6M Performance:
+22.56%
1Y Performance:
-24.68%
1-Day Range:
$1.07
$1.12
1-Week Range:
$1.07
$1.21
52-Week Range:
$0.8101
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Name
Enlivex Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare ENLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.10 | 27.94M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-02-21 | Reiterated | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Stock (ENLV) Latest News
Enlivex Therapeutics Ltd. stock outlook for YEARPrice Action & Stepwise Entry and Exit Trade Signals - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Petoskey News-Review
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Canton Repository
Will Enlivex Therapeutics Ltd. stock recover after recent dropProfit Target & Daily Technical Stock Forecast Reports - newser.com
How sentiment analysis helps forecast Enlivex Therapeutics Ltd.2025 Sector Review & Growth Focused Stock Pick Reports - newser.com
Sector ETF performance correlation with Enlivex Therapeutics Ltd.2025 Earnings Impact & High Conviction Trade Alerts - newser.com
Will Enlivex Therapeutics Ltd. see short term momentumM&A Rumor & Verified Swing Trading Watchlists - newser.com
How Enlivex Therapeutics Ltd. stock performs in weak economyMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
Using R and stats models for Enlivex Therapeutics Ltd. forecastingMarket Movement Recap & Community Driven Trade Alerts - newser.com
Here's Why We're Watching Enlivex Therapeutics' (NASDAQ:ENLV) Cash Burn Situation - simplywall.st
Visual trend scoring systems applied to Enlivex Therapeutics Ltd.2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Is Enlivex Therapeutics Ltd. stock reversal real or fakeJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Will Enlivex Therapeutics Ltd. stock maintain momentum in 2025Market Growth Summary & Real-Time Volume Trigger Notifications - newser.com
Can volume confirm reversal in Enlivex Therapeutics Ltd.2025 Risk Factors & Weekly Hot Stock Watchlists - newser.com
Candlestick signals on Enlivex Therapeutics Ltd. stock todayWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
What Fibonacci levels say about Enlivex Therapeutics Ltd. reboundPortfolio Growth Summary & Intraday High Probability Setup Alerts - newser.com
Published on: 2025-10-03 04:25:17 - newser.com
Building trade automation scripts for Enlivex Therapeutics Ltd.2025 EndofYear Setup & Trade Opportunity Analysis Reports - newser.com
How rising interest rates impact Enlivex Therapeutics Ltd. stockJuly 2025 Recap & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-10-03 06:15:35 - newser.com
Enlivex Therapeutics Ltd Stock (ENLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):